A groundbreaking implantable device has significantly reduced the frequency and severity of seizures in children with severe epilepsy, according to a new UK clinical trial. The rechargeable device, attached to the skull, delivers constant electrical stimulation to the brain, allowing patients like Oran to experience dramatic improvements in quality of life. This trial, known as the CADET pilot, is the first to measure this treatment for pediatric epilepsy and shows promise for broader applications. Further research will expand to more patients, aiming for a new standard in epilepsy treatment.
